Histiocytic Sarcoma: Challenging Course, Dismal Outcome

Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm derived from non-Langerhans histiocytic cells of the monocyte/macrophage system. With an incidence of 0.17/million individuals and a slight male preference, HS presents with a wide age distribution. Most commonly, it occurs as a primary malig...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Kim Francis, Sjö, Lene Dissing, Kampmann, Peter, Pedersen, Torben Bridstrup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Interesting Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918796/
https://www.ncbi.nlm.nih.gov/pubmed/33671860
http://dx.doi.org/10.3390/diagnostics11020310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918796/
https://www.ncbi.nlm.nih.gov/pubmed/33671860
http://dx.doi.org/10.3390/diagnostics11020310

Ejemplares similares